TNFRSF10B and neoplasm: CDK4/6 inhibitors also lower the apoptotic threshold of tumor cells by inhibiting the phosphorylation of P73, leading to nuclear translocation of P73, and inducing activation of DR5, allowing tumor cells to be readily affected by multiple therapeutic modalities (Tong et al., 2022).